Company Filing History:
Years Active: 2013
Title: Innovations in Cancer Diagnosis by Pil Je Park
Introduction
Pil Je Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer diagnosis through his innovative methods. His work focuses on the detection and screening of various types of cancer, which can greatly enhance early diagnosis and treatment options.
Latest Patents
Pil Je Park holds a patent for a method that monitors, diagnoses, and screens cancer by measuring the concentration of des-R prothrombin activation peptide fragment F2 (des-R F2) in serum. This invention specifically targets liver cancer, breast cancer, and stomach cancer. The method involves quantifying the expression of des-R F2, a protein marker that is down-regulated in patients with these cancers. By comparing the levels of this protein marker in normal subjects and cancer patients, the method provides a reliable means for diagnosis and screening.
Career Highlights
Pil Je Park is associated with Bioinfra Inc., where he continues to develop and refine his innovative approaches to cancer diagnosis. His work has the potential to significantly impact the medical field by providing more accurate and timely cancer screenings.
Collaborations
He collaborates with notable colleagues, including Chul Woo Kim and Yong-Sung Shin, who contribute to the research and development efforts at Bioinfra Inc. Their combined expertise enhances the effectiveness of their projects and innovations.
Conclusion
Pil Je Park's contributions to cancer diagnosis through his patented methods represent a significant advancement in medical technology. His work not only aids in early detection but also paves the way for improved treatment strategies for cancer patients.